SES AI to announce Q2FY26 results on August 11

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

SES AI Corporation announced it will release its Q2FY26 financial results on August 11, 2026, followed by a conference call at 5:00 p.m. ET. The company provides webcast and dial-in options for investors to access the discussion. SES AI specializes in AI-enhanced Li-Metal batteries for electric transportation.

powered bylight_fuzz_icon
46125173

*this image is generated using AI for illustrative purposes only.

SES AI Corporation will release its financial results for the second quarter of 2026 after market close on Tuesday, August 11, 2026. The company, a developer of AI-enhanced high-performance Li-Metal and Li-ion batteries, will hold a conference call on the same day at 5:00 p.m. ET to discuss the performance.

Conference Call Details

Investors can access the live conference call via webcast through SES AI’s Investor Relations website at https://investors.ses.ai . Advance registration for the call is available at https://events.q4inc.com/attendee/167359368 .

Dial-in Information

Region Phone Number Access Code
United States (Toll Free) +1 833-461-5787 167359368
International +1 626-884-3620 167359368

A webcast replay will be available shortly after the call concludes at https://investors.ses.ai/events-and-presentations/events/default.aspx .

Company Overview

SES AI Corp. (NYSE: SES) focuses on developing and manufacturing Li-Metal batteries for electric transportation on land and in the air. The company integrates artificial intelligence across its operations, including research, materials sourcing, cell design, and manufacturing. Founded in 2012, SES AI is headquartered in Boston with operations in Singapore, Shanghai, and Seoul.

Investors can find additional financial information and updates on the company’s website at www.ses.ai .

What key performance indicators will investors focus on during the Q2 2026 earnings call?

How might the results impact SES AI's position in the competitive Li-Metal battery market?

Could the earnings call reveal new partnerships or advancements in AI integration for battery technology?

like19
dislike

SES AI receives NYSE notice over low stock price

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

SES AI Corporation was notified by the NYSE on July 17, 2026, that its Class A common stock is non-compliant due to an average closing price below $1.00 over 30 consecutive trading days. The company has six months to rectify this by achieving a closing price and 30-day average of at least $1.00. SES AI's stock will continue trading during this cure period.

powered bylight_fuzz_icon
46094505

*this image is generated using AI for illustrative purposes only.

SES AI Corporation received a notice from the New York Stock Exchange (NYSE) on July 17, 2026, stating it is not in compliance with Section 802.01C of the NYSE Listed Company Manual. The non-compliance occurred because the average closing price of its Class A common stock was less than $1.00 per share over a period of 30 consecutive trading days. This average closing price is the minimum required to maintain continued listing on the NYSE.

SES AI plans to respond to the NYSE within 10 business days of receiving the notice. The response will outline its intent to cure the deficiency and return to compliance with the NYSE's continued listing requirements. The company's Class A common stock will continue to be listed and trade on the NYSE during this period, provided it complies with other NYSE continued listing standards.

To regain compliance, SES AI must meet specific price criteria within a six-month period following the receipt of the notice. The company can cure the deficiency if, on the last trading day of any calendar month during this period, its Class A common stock has a closing share price of at least $1.00. Additionally, the average closing share price must be at least $1.00 over the 30 trading-day period ending on that last trading day.

Under NYSE rules, if SES AI determines that curing the stock price deficiency requires an action needing stockholder approval at its next annual meeting, the price condition will be considered cured differently. In this scenario, the price must promptly exceed $1.00 per share and remain above that level for at least the following 30 trading days.

Compliance Timeline and Conditions

The following table outlines the conditions for SES AI to regain compliance with the NYSE listing standards:

Condition Requirement
Cure Period Six months from receipt of notice
Minimum Closing Price $1.00 per share on last trading day of a calendar month
Minimum Average Price $1.00 per share over 30 trading-day period ending on last trading day of month
Alternative Cure (Stockholder Approval) Price exceeds $1.00 and remains above for 30 trading days

What strategic measures will SES AI implement to boost its share price above the $1.00 threshold within the six-month cure period?

How might the potential need for stockholder approval to cure the deficiency influence the company's upcoming annual meeting agenda?

What impact could the NYSE non-compliance notice have on investor confidence and SES AI's ability to secure future financing?

like17
dislike

More News on SES AI Corp